Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Neurotest Tampere Oy
OY
Active
Y-tunnus 0577762-8
Pl 17, 33101
Tampere
Medical specialists activities
· NACE 8622
Est. 1983
— employees
Watchlist
Share
Finland
/
Companies
/
Medical specialists activities
/
Neurotest Tampere Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
84M
168M
252M
336M
3M
2021
3M
2022
292M
2023
3M
2024
2M
2025
EBITDA
EUR millions
0M
2M
5M
7M
9M
0M
2021
0M
2022
8M
2023
0M
2024
0M
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
2 762
2 877
292 446
2 704
2 188
Staff expenses
−23
−24
−2 696
−27
−27
EBITDA
21
24
7 838
37
19
Depreciation & amort.
−2
−1
−101
−1
−1
EBIT
20
22
7 737
36
18
Net financials
−0
−0
1
−0
−0
Profit before tax
20
22
7 738
36
18
Tax
4
4
15
7
4
Net profit
16
18
6 191
28
15
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
723
772
744
674
660
Equity
159
164
213
224
221
Long-term debt
—
—
0
0
0
Short-term debt
564
608
532
450
440
Total debt
564
608
532
450
440
Financial ratios
5-year trend
EBITDA margin
0.9%
This company
15.8%
Market median
-94% vs market
2021
2025
Equity ratio
33.4%
This company
38.2%
Market median
+13% vs market
2021
2025
Return on equity
6.6%
This company
18.4%
Market median
-64% vs market
2021
2025
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
2021
2025
Asset turnover
3.31×
This company
1.12×
Market median
+196% vs market
2021
2025
Debt / equity
1.99×
This company
0.62×
Market median
-221% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Neurotest Tampere Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network